blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1034778

EP1034778 - Use of octocrylene to solubilise 2,4-bis-[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl-6-(4-methoxyphenyl)-1,3,5-triazin in cosmetic or dermatologic radiation screening compositions [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.04.2005
Database last updated on 03.10.2024
Most recent event   Tooltip14.12.2007Lapse of the patent in a contracting state
New state(s): PT		published on 16.01.2008  [2008/03]
Applicant(s)For all designated states
Beiersdorf AG
Unnastrasse 48
20253 Hamburg / DE
[N/P]
Former [2004/22]For all designated states
Beiersdorf AG
Unnastrasse 48
20253 Hamburg / DE
Former [2000/37]For all designated states
Beiersdorf AG
Unnastrasse 48
20245 Hamburg / DE
Inventor(s)01 / Gers-Barlag, Heinrich, Dr.
Kiebitzgrund 11
25495 Kummerfeld / DE
02 / Müller, Anja
Wiesenstrasse 5
23843 Rümpel / DE
[2000/37]
Application number, filing date00103661.522.02.2000
[2000/37]
Priority number, dateDE199911047710.03.1999         Original published format: DE 19910477
[2000/37]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP1034778
Date:13.09.2000
Language:DE
[2000/37]
Type: A3 Search report 
No.:EP1034778
Date:16.08.2001
[2001/33]
Type: B1 Patent specification 
No.:EP1034778
Date:26.05.2004
Language:DE
[2004/22]
Search report(s)(Supplementary) European search report - dispatched on:EP28.06.2001
ClassificationIPC:A61K7/42
[2000/37]
CPC:
A61Q17/04 (EP,US); A61K8/4966 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/37]
TitleGerman:Verwendung von Octocrylen zur Solubilisierung von 2,4-Bis- [4-(2-Ethyl-hexyloxy)-2-hydroxy]-phenyl -6-(4-methoxyphenyl)-1,3,5-triazin in kosmetischen oder dermatologischen Lichtschutzmitteln[2000/37]
English:Use of octocrylene to solubilise 2,4-bis-[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl-6-(4-methoxyphenyl)-1,3,5-triazin in cosmetic or dermatologic radiation screening compositions[2000/37]
French:Utilisation d'octocrylene pour solubiliser 2,4-bis-[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl-6-(4-metho xyphenyl)-1,3,5-triazine dans des compositions cosmétiques ou dermatologiques photoprotectrices[2000/37]
Examination procedure04.07.2001Examination requested  [2001/35]
18.11.2003Communication of intention to grant the patent
29.03.2004Fee for grant paid
29.03.2004Fee for publishing/printing paid
Opposition(s)01.03.2005No opposition filed within time limit [2005/20]
Fees paidRenewal fee
08.02.2002Renewal fee patent year 03
29.01.2003Renewal fee patent year 04
01.03.2004Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipFI26.05.2004
IE26.05.2004
NL26.05.2004
DK26.08.2004
GR26.08.2004
PT26.10.2004
AT22.02.2005
CY22.02.2005
LU22.02.2005
BE28.02.2005
CH28.02.2005
LI28.02.2005
MC28.02.2005
[2008/03]
Former [2007/20]FI26.05.2004
IE26.05.2004
NL26.05.2004
DK26.08.2004
GR26.08.2004
AT22.02.2005
CY22.02.2005
LU22.02.2005
BE28.02.2005
CH28.02.2005
LI28.02.2005
MC28.02.2005
Former [2007/08]FI26.05.2004
IE26.05.2004
NL26.05.2004
DK26.08.2004
GR26.08.2004
AT22.02.2005
LU22.02.2005
BE28.02.2005
CH28.02.2005
LI28.02.2005
MC28.02.2005
Former [2006/34]FI26.05.2004
IE26.05.2004
NL26.05.2004
DK26.08.2004
GR26.08.2004
AT22.02.2005
BE28.02.2005
CH28.02.2005
LI28.02.2005
MC28.02.2005
Former [2006/14]FI26.05.2004
IE26.05.2004
NL26.05.2004
DK26.08.2004
GR26.08.2004
BE28.02.2005
CH28.02.2005
LI28.02.2005
MC28.02.2005
Former [2006/13]FI26.05.2004
IE26.05.2004
NL26.05.2004
DK26.08.2004
GR26.08.2004
BE28.02.2005
Former [2005/19]FI26.05.2004
IE26.05.2004
DK26.08.2004
GR26.08.2004
Former [2005/18]FI26.05.2004
DK26.08.2004
GR26.08.2004
Former [2005/06]FI26.05.2004
GR26.08.2004
Former [2005/02]FI26.05.2004
Documents cited:Search[Y]EP0685221  (OREAL [FR]) [Y] 1-4 * abstract * * page 3, line 18 - line 36 * * claim - *;
 [Y]US5605679  (HANSENNE ISABELLE [FR], et al) [Y] 1-4 * column 2, line 32 - line 62 * * column 3, line 1 - line 8 * * column 4, line 17 - line 25 * * claim - *;
 [Y]EP0775698  (CIBA GEIGY [CH]) [Y] 1-4 * abstract * * page 10; example 1 * * page 17; example 11 * * claim - *;
 [A]EP0821941  (3V SIGMA SPA [IT]) [A] 1-4 * page 3, line 20 - line 23 ** claim - *;
 [Y]WO9908653  (CIBA GEIGY AG [CH], et al) [Y] 1-4 * page 10, paragraph L * * claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.